跳至主要内容
临床试验/CTIS2023-504360-42-00
CTIS2023-504360-42-00招募中1 期

ess Bleeding by Omitting Aspirin in Non-ST-segment Elevation Acute Coronary Syndrome Patients

Amsterdam UMC0 个研究点目标入组 3,090 人开始时间: 2023年3月10日最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
发起方
入组人数
3,090

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

年龄范围
18 至 65+(—)
性别
All

入选标准

  • Clinical diagnosis of NSTE-ACS (i.e. NSTEMI or unstable angina), Successful PCI (according to the treating physician)

排除标准

  • Known allergy or contraindication for aspirin or all commercially available P2Y12-inhibitors (i.e. ticagrelor, prasugrel and clopidogrel), Concurrent use of oral anticoagulants (e.g. because of atrial fibrillation), Ongoing indication for DAPT at admission (e.g. due to recent PCI or ACS), Planned surgical intervention within 12 months of PCI, Pregnant or breastfeeding women at time of enrolment, Participation in another trial with an investigational drug or device

研究者

发起方
Amsterdam UMC

相似试验